|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.68 USD | -2.33% |
|
-7.80% | -44.56% |
| Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
| Apr. 02 | Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024. | CI |
Fortress Biotech, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 0.103 million compared to USD 0.192 million a year ago. Revenue was USD 84.51 million compared to USD 75.74 million a year ago.
Net loss was USD 60.64 million compared to USD 86.58 million a year ago. Basic loss per share from continuing operations was USD 8.47 compared to USD 15.97 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -44.56% | 33.08M | |
| -3.45% | 87.17B | |
| +2.76% | 40.1B | |
| -17.08% | 31.38B | |
| +57.86% | 25.12B | |
| -16.27% | 15.59B | |
| -9.12% | 12B | |
| -42.56% | 11.8B | |
| -17.41% | 11.8B | |
| +6.89% | 8.81B |
FORTRESS BIOTECH, INC. 
